These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1190623)

  • 1. Lack of effect of rifampin on the antibody response to a viral antigen in patients with tuberculosis.
    Silvestri LG
    Am Rev Respir Dis; 1975 Nov; 112(5):739-41. PubMed ID: 1190623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled double-blind study of the effect of rifampin on humoral and cellular immune responses in patients with pulmonary tuberculosis and in tuberculosis contacts.
    Humber DP; Nsanzumuhire H; Aluoch JA; Webster AD; Aber VR; Mitchison DA; Girling DJ; Nunn AJ
    Am Rev Respir Dis; 1980 Sep; 122(3):425-36. PubMed ID: 7416618
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin-dependent antibodies in twice-weekly treated patients.
    Algeorge G; Rudescu D; Alexandrescu D
    Scand J Respir Dis Suppl; 1973; 84():98-101. PubMed ID: 4522081
    [No Abstract]   [Full Text] [Related]  

  • 4. Light chain proteinuria and humoral immunoincompetence in tuberculous patients treated with rifampin.
    Graber CD; Jebaily J; Galphin RL; Doering E
    Am Rev Respir Dis; 1973 May; 107(5):713-7. PubMed ID: 4695622
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
    Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin-dependent antibodies during intermittent treatment.
    Virgilio R
    Scand J Respir Dis Suppl; 1973; 84():83-6. PubMed ID: 4593269
    [No Abstract]   [Full Text] [Related]  

  • 7. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. The detection of rifampicin-dependent antibodies.
    Worlledge S
    Scand J Respir Dis Suppl; 1973; 84():60-3. PubMed ID: 4544603
    [No Abstract]   [Full Text] [Related]  

  • 8. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Correlation between the presence of rifampicin-dependent antibodies and the clinical data.
    Worlledge S
    Scand J Respir Dis Suppl; 1973; 84():125-8. PubMed ID: 4522065
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifampin and cell-mediated immune responses in tuberculosis.
    Goldstein RA; Ang UH; Foellmer JW; Janicki BW
    Am Rev Respir Dis; 1976 Feb; 113(2):197-202. PubMed ID: 1247234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term therapy with rifampin and the secondary antibody response to killed influenza vaccine.
    Miller WT
    Am Rev Respir Dis; 1978 Mar; 117(3):605-7. PubMed ID: 629491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study concerning the early immunosuppressive effects of rifampin in man.
    Litwin A; Brooks SM; Claes F
    Chest; 1974 May; 65(5):548-51. PubMed ID: 4856954
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of clinical characteristics between rifampin-dependent and rifampin- resistant patients with pulmonary tuberculosis].
    Li Y; Tan S; Luo C; Li Y; Qin H; Feng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):287-9. PubMed ID: 23443791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-immunological substantiation of the use of rifampicin in the combined therapy of adults and adolescents with destructive pulmonary tuberculosis].
    Chernushenko EF; Kogosova LS; Il'nitskiĭ IG; Petrashenko AI; Goncharova SI
    Probl Tuberk; 1989; (7):39-43. PubMed ID: 2798385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampin.
    Sanders WE
    Ann Intern Med; 1976 Jul; 85(1):82-6. PubMed ID: 937928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of T-lymphocyte rosettes by rifampin. Studies in normals and patients with tuberculosis.
    Gupta S; Grieco MH; Siegel I
    Ann Intern Med; 1975 Apr; 82(4):484-8. PubMed ID: 1078970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological changes during intermittent treatment with rifampicin.
    Wislawska-Orlowska B; Pniewski T
    Scand J Respir Dis Suppl; 1973; 84():94-7. PubMed ID: 4522080
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.